PortfoliosLab logoPortfoliosLab logo
ARKG vs. ARKB
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ARKG vs. ARKB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK 21Shares Bitcoin ETF (ARKB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARKG achieves a 24.30% return, which is significantly higher than ARKB's -28.79% return.


ARKG

1D
-1.07%
1M
17.41%
YTD
24.30%
6M
19.48%
1Y
52.71%
3Y*
3.17%
5Y*
-16.56%
10Y*
8.67%

ARKB

1D
-3.18%
1M
-17.72%
YTD
-28.79%
6M
-28.93%
1Y
-39.74%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. ARKB - Yearly Performance Comparison


2026 (YTD)20252024
ARKG
ARK Genomic Revolution Multi-Sector ETF
24.30%23.04%-26.95%
ARKB
ARK 21Shares Bitcoin ETF
-28.79%-6.59%86.54%

Correlation

The correlation between ARKG and ARKB is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.37

Correlation (All Time)
Calculated using the full available price history since Jan 11, 2024

0.38

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARKG vs. ARKB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG
ARKG Risk / Return Rank: 3636
Overall Rank
ARKG Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3838
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3434
Omega Ratio Rank
ARKG Calmar Ratio Rank: 4040
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3232
Martin Ratio Rank

ARKB
ARKB Risk / Return Rank: 22
Overall Rank
ARKB Sharpe Ratio Rank: 22
Sharpe Ratio Rank
ARKB Sortino Ratio Rank: 22
Sortino Ratio Rank
ARKB Omega Ratio Rank: 22
Omega Ratio Rank
ARKB Calmar Ratio Rank: 22
Calmar Ratio Rank
ARKB Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. ARKB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK 21Shares Bitcoin ETF (ARKB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARKGARKBDifference
Sharpe ratioReturn per unit of total volatility

+2.15

Sortino ratioReturn per unit of downside risk

+3.17

Omega ratioGain probability vs. loss probability

1.22

0.86

+0.36

Calmar ratioReturn relative to maximum drawdown

1.93

-0.77

+2.69

Martin ratioReturn relative to average drawdown

4.58

-1.30

+5.89

ARKG vs. ARKB - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.25, which is higher than the ARKB Sharpe Ratio of -0.90. The chart below compares the historical Sharpe Ratios of ARKG and ARKB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ARKG vs. ARKB - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than ARKB's maximum drawdown of -52.04%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKB.


Loading charts...

Drawdown Indicators


ARKGARKBDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-52.04%

-31.55%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

-52.04%

+24.53%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-67.78%

-50.41%

-17.37%

Average Drawdown

Average peak-to-trough decline

-36.02%

-16.87%

-19.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.53%

30.54%

-19.01%

Volatility

ARKG vs. ARKB - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.19% compared to ARK 21Shares Bitcoin ETF (ARKB) at 13.08%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than ARKB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARKGARKBDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.19%

13.08%

+2.11%

Volatility (6M)

Calculated over the trailing 6-month period

30.91%

34.51%

-3.60%

Volatility (1Y)

Calculated over the trailing 1-year period

42.54%

44.12%

-1.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.93%

50.05%

-4.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.29%

50.05%

-8.76%

ARKG vs. ARKB - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than ARKB's 0.21% expense ratio.


Dividends

ARKG vs. ARKB - Dividend Comparison

Neither ARKG nor ARKB has paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
ARKB
ARK 21Shares Bitcoin ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%

Frequently Asked Questions


ARKG and ARKB have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (15.19%) compared to ARKB (13.08%). In terms of maximum drawdown, ARKG dropped -83.59% vs ARKB's -52.04%.

On 1-year performance, ARKG leads with 52.71% vs -39.74% for ARKB. On fees, ARKB is cheaper at 0.21% per year. On volatility, ARKB has been the lower-risk option at 13.08%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, ARKG has performed better with a 52.71% return vs -39.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

ARKB is cheaper with a 0.21% expense ratio, compared with 0.75% for ARKG.

ARKG and ARKB have nearly identical dividend yields, around 0.00%.

ARKG is categorized as Health & Biotech Equities, while ARKB is Cryptocurrency. Their fees differ too: 0.75% for ARKG and 0.21% for ARKB.

ARKG currently has the higher Sharpe Ratio (1.25 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARKG and ARKB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer